✦ LIBER ✦

EBT-P Magnet Development Program summary

✍ Scribed by McManamy, T.; Lue, J.; Ballou, J.; Mann, T.; Shen, S.; Wilson, C.

Book ID: 114647705
Publisher: IEEE
Year: 1985
Tongue: English
Weight: 691 KB
Volume: 21
Category: Article
ISSN: 0018-9464
DOI: 10.1109/tmag.1985.1063771

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Magnet Development Program at the WHMFC

✍ Li, L.; Peng, T.; Xiao, H.X.; Lv, Y.L.; Pan, Y.; Herlach, F. 📂 Article 📅 2012 🏛 IEEE 🌐 English ⚖ 558 KB

Summary of magnet development in the pas

Summary of magnet development in the past two years

✍ H. H. Stadelmaier 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 829 KB

The United States superconducting MHD ma

The United States superconducting MHD magnet technology development program

✍ Dawson, A.; Marston, P.; Thome, R.; Iwasa, Y.; Tarrh, J. 📂 Article 📅 1981 🏛 IEEE 🌐 English ⚖ 693 KB

Summary: Developing a successful measure

Summary: Developing a successful measurement program

✍ Baugher, Dan 📂 Article 📅 1981 🏛 Wiley (John Wiley & Sons) ⚖ 269 KB

The OptiMARK clinical development progra

The OptiMARK clinical development program: Summary of safety data

✍ Jeffrey J. Brown; Rita M. Kristy; Gary R. Stevens; Joseph A. Pierro 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## Purpose To describe and summarize the safety data from the OptiMARK clinical development program. ## Materials and Methods In the 18 clinical studies comprising the clinical program, doses ranging from 0.1 to 0.7 mmol/kg were administered to healthy adult volunteers, patients with

Tore Supra--Status report concerning the

Tore Supra--Status report concerning the superconducting magnet after the qualifying development program

✍ Aymar, R.; Mardion, G.B.; Claudet, G.; Disdier, F.; Duthil, R.; Genevey, P.; Ham 📂 Article 📅 1981 🏛 IEEE 🌐 English ⚖ 452 KB